Zobrazeno 81 - 90
of 169
pro vyhledávání: ''
Autor:
Cristina Mazzali, Spinello Antinori, Massimo Galli, Micol Olivetti, Ilaria Caramma, M. Cesari, Laura Milazzo
Publikováno v:
The Journal of antimicrobial chemotherapy. 65(4)
OBJECTIVES Recent reports demonstrated in vitro the efficacy of fluvastatin in inhibiting hepatitis C virus (HCV) replication and a synergistic effect in association with interferon-alpha (IFN-alpha). In vivo the inhibition of HCV replication by stat
Autor:
Pierre-Marie Girard, Jean-Luc Meynard, Karine Lacombe, Laurence Morand-Joubert, Laurence Slama, Jean-Marie Poirier, Marc-Antoine Valantin
Publikováno v:
The Journal of antimicrobial chemotherapy. 65(1)
BACKGROUND It is debated whether a risk of protease inhibitor mutation selection in proviral DNA exists during intermittent HIV-1 viraemia thereby impacting long-term virological control. METHODS Virologically controlled patients treated with lopinav
Autor:
Wolfgang, Stöhr, David, Back, David, Dunn, Caroline, Sabin, Alan, Winston, Richard, Gilson, Deenan, Pillay, Teresa, Hill, Jonathan, Ainsworth, Brian, Gazzard, Clifford, Leen, Loveleen, Bansi, Martin, Fisher, Chloe, Orkin, Jane, Anderson, Margaret, Johnson, Philippa, Easterbrook, Sara, Gibbons, Saye, Khoo, Valerie, Delpech
Publikováno v:
Scopus-Elsevier
BACKGROUND The protease inhibitors lopinavir and atazanavir are both recommended for treatment of HIV-infected patients. Considerable inter-individual variability in plasma concentration has been observed for both drugs. The aim of this study was to
Publikováno v:
The Journal of antimicrobial chemotherapy. 64(5)
OBJECTIVES This study was designed to investigate the neutrophil-targeted anti-inflammatory potential of posaconazole (0.1-5 microM, equivalent to 0.7-3.9 mg/L) by measuring the effects of this agent on the release of leukotriene B(4) (LTB(4)) and st
Autor:
Daneshia Roberts-Pollack, Aida E. Casiano-Colón, Brandon Kitchel, Andrea M. Hujer, Paul D. Fiorella, Andrea Endimiani, Fred C. Tenover, John M. DePasquale, Nancy Pickens, Robert A. Bonomo, Federico Perez, Sandra Forero
Publikováno v:
The Journal of antimicrobial chemotherapy. 64(5)
To characterize isolates of Klebsiella pneumoniae producing KPC carbapenemase (KPC-Kp) associated with an outbreak in a long-term acute care hospital (LTACH) in South Florida.During 21 March to 20 April 2008, 241 K. pneumoniae isolates detected at In
Autor:
Richard Phillips, David F. Bibby, David Chadwick, Fred S. Sarfo, Matthias T. Dittmar, Uli Schwab, Paul Collini, Ingrid Green, Lambert Tetteh Appiah, Duncan A. Clark
Publikováno v:
The Journal of antimicrobial chemotherapy. 64(3)
1. Klastersky JA. Use of imipenem as empirical treatment of febrile neutropenia. Int J Antimicrob Agents 2003; 21: 393–402. 2. Hughes WT, Armstrong D, Bodey GP et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with
Autor:
Danai Vitti, Athanassios Tsakris, Evangelia Voulgari, Maria Tsalidou, Spyros Pournaras, Evangelia Dimitroulia, Efthimia Protonotariou, Danai Sofianou, Antonios N. Maniatis, Ioulia Kristo
Publikováno v:
The Journal of antimicrobial chemotherapy. 64(2)
Objectives KPC-possessing Klebsiella pneumoniae have been found to be widespread in several regions but are still rarely detected in Europe. We describe the characteristics of an outbreak caused by KPC producers in a tertiary care Greek hospital. Met
Autor:
Pierre-Marie, Girard, André, Cabié, Christian, Michelet, Renaud, Verdon, Christine, Katlama, Patrick, Mercié, Laurence, Morand-Joubert, Pascal, Pétour, Françoise, Monchecourt, Geneviève, Chêne, Aldo, Trylesinski, D, Zucman
Publikováno v:
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2009, 64 (1), pp.126-34. ⟨10.1093/jac/dkp141⟩
Journal of Antimicrobial Chemotherapy, 2009, 64 (1), pp.126-34. ⟨10.1093/jac/dkp141⟩
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2009, 64 (1), pp.126-34. ⟨10.1093/jac/dkp141⟩
Journal of Antimicrobial Chemotherapy, 2009, 64 (1), pp.126-34. ⟨10.1093/jac/dkp141⟩
International audience; OBJECTIVES: To assess simplified maintenance regimens containing dual antiretroviral drugs in patients with controlled human immunodeficiency virus type 1 infection. METHODS: A non-inferiority, randomized, multicentre, open-la
Autor:
J, Berenguer, J, González-García, J, López-Aldeguer, M A, Von-Wichmann, C, Quereda, A, Hernando, J, Sanz, C, Tural, E, Ortega, J, Mallolas, I, Santos, P, Miralles, M L, Montes, J M, Bellón, H, Esteban
Publikováno v:
The Journal of antimicrobial chemotherapy. 63(6)
OBJECTIVES The two currently available types of pegylated interferon (peg-IFN) used to treat hepatitis C have different pharmacokinetic properties. It is unclear how these differences affect response to therapy. We compared the effectiveness and safe
Autor:
Geetha Ramachandran, K. Ramesh, Soumya Swaminathan, S. Rajasekaran, Mahalingam Vasantha, Agibothu Kupparam Hemanth Kumar, G. Narendran, Chandrasekaran Padmapriyadarsini, Ishaan Jagan
Publikováno v:
The Journal of antimicrobial chemotherapy. 63(4)